{"id":"W2908942081","doi":"10.2217/imt-2018-0167","title":"Immune Checkpoint Inhibitors and Non-Small-Cell Lung Cancer Management: 2018 Update","year":2019,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Pembrolizumab; Atezolizumab; Nivolumab; Medicine; Lung cancer; Oncology; Internal medicine; Docetaxel; Avelumab; Ipilimumab; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004564513,0.00181955,0.002560754,0.002338967,0.001124205,0.003916559,0.001886284,0.006599987,0.003875439],"category_scores_gemma":[0.0144227,0.0006292951,0.001532367,0.00117182,0.001161344,0.002887446,0.001217747,0.01372575,0.003812478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002174282,"about_ca_system_score_gemma":0.002410806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001380802,"about_ca_topic_score_gemma":0.004705093,"domain_scores_codex":[0.9976059,0.0005450699,0.0004244596,0.000242099,0.001015306,0.0001672324],"domain_scores_gemma":[0.9893458,0.004895127,0.0009505489,0.0001326671,0.003681347,0.0009944296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006540905,0.00001727646,0.0000651228,0.0005274537,0.00003380241,0.00008908976,0.000009857769,0.00003580052,0.00006071067,0.0004218042,0.9685972,0.03007644],"study_design_scores_gemma":[0.0001127688,0.00005887864,0.0004053198,0.001332253,0.0001482438,0.0004286717,0.00003470365,0.0001889929,0.0001071762,0.0008532949,0.9963065,0.00002313756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00008455106,0.06807377,0.0002732042,0.05826679,0.8712261,0.00001775247,0.00007564811,0.000055969,0.001926152],"genre_scores_gemma":[0.0007005686,0.04713677,0.0002572252,0.04198385,0.9046177,0.00002101882,0.00007172526,0.00002703259,0.005184126],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.006599987,"threshold_uncertainty_score":0.0241397,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005902408804642505,"score_gpt":0.2602707838035951,"score_spread":0.2543683749989526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}